Načítá se...
Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development
BACKGROUND: Accumulating evidence suggests that the C-C chemokine ligand 2 (CCL2, or monocyte chemoattractant protein 1) acts as a neuromodulator in the central nervous system through its binding to the C-C chemokine receptor 2 (CCR2). Notably, it is well established that the CCL2/CCR2 axis plays a...
Uloženo v:
| Vydáno v: | Mol Pain |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4956154/ https://ncbi.nlm.nih.gov/pubmed/27306408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1744806916653969 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|